These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8358057)

  • 21. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
    Bollack C; Rougeron G
    Am J Clin Oncol; 1988; 11 Suppl 2():S156-9. PubMed ID: 2977270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems and principles of hormone therapy of advanced prostate cancer].
    Altwein JE; Faul P
    Klin Wochenschr; 1990 Apr; 68(7):347-58. PubMed ID: 1692896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal therapy of prostate cancer.
    Labrie F
    Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone treatments in the common 'hormone-dependent' carcinomas.
    Wood BC
    Palliat Med; 1993; 7(4):257-72. PubMed ID: 7505186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.
    Sharifi N
    Expert Opin Investig Drugs; 2010 Jul; 19(7):837-46. PubMed ID: 20524793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine therapy: where do we stand and where are we going?
    Schröder FH
    Cancer Surv; 1991; 11():177-94. PubMed ID: 1841751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary hormonal manipulation.
    Merseburger AS; Belka C; Behmenburg K; Stenzl A
    Front Radiat Ther Oncol; 2008; 41():93-102. PubMed ID: 18544990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cabazitaxel for the treatment of prostate cancer.
    Michielsen DP; Braeckman JG; Denis L
    Expert Opin Pharmacother; 2011 Apr; 12(6):977-82. PubMed ID: 21406025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Castration refractory prostate cancer: cinderella finally comes to the ball.
    Chowdhury S; Harper P; Powles T
    Onkologie; 2010; 33(12):655-6. PubMed ID: 21124035
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in hormonal therapy for advanced prostate cancer.
    Oottamasathien S; Crawford ED
    Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
    Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N
    Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone-releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant.
    Marks LS
    Urology; 2003 Dec; 62(6 Suppl 1):36-42. PubMed ID: 14706507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
    Geller J; Albert J; Vik A
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current topics and perspectives relating to hormone therapy for prostate cancer.
    Suzuki H; Kamiya N; Imamoto T; Kawamura K; Yano M; Takano M; Utsumi T; Naya Y; Ichikawa T
    Int J Clin Oncol; 2008 Oct; 13(5):401-10. PubMed ID: 18946750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary hormonal therapy.
    Smith DC
    Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Managing side effects of androgene deprivation in prostate cancer].
    Thalgott M; Gschwend JE; Retz M
    MMW Fortschr Med; 2010 Oct; 152(41):40-3. PubMed ID: 21090376
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal therapy for locally advanced prostate cancer.
    Einstein AB
    NCI Monogr; 1988; (7):171-4. PubMed ID: 3050536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer of the prostate: new hormone therapies].
    Namer M; Boublil JL; Kather R; Cavaglione G
    Bull Cancer; 1986; 73(1):47-55. PubMed ID: 3779122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.